Ballicules.com

Nalmefene

opioid antag.

What it isLong-acting opioid receptor antagonist used intranasally for emergency reversal of known or suspected opioid overdose.

Why this oneIts duration is longer than naloxone’s and may better match long-acting or high-potency synthetic opioids.

What limits itIt can precipitate severe, prolonged withdrawal and does not replace ventilation, repeat dosing, surveillance, or emergency care.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Opioid overdose (emergency reversal)Adults & peds ≥12 yr1.5 mg IM/SC1.5 mg IM/SCrepeat q2–5 min PRN (new auto-injector each dose)

Renal No adjustment needed for single episodes of opioid antagonism (clearance reduced in impairment)

Hepatic No adjustment needed for single episodes of opioid antagonism (clearance reduced in impairment)

Repeat every 2–5 min with a new auto-injector until emergency help arrives

Instructions

Cautions

Adverse reactions

Pregnancy No human data; do not withhold for opioid overdose; no embryo-fetal harm in animals

Lactation No human data; present in rat milk

NO BOXED WARNINGS

Principal risksevere, prolonged precipitated opioid withdrawal

Cost, est. cash$75–$200/2-dose kit

Generic entryBy 2023

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger0 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityUsually well tolerated; abrupt opioid withdrawal can be severe and prolonged.

Mechanism of action: Nalmefene ballicule

Nalmefene ballicule: receptor binding, kinetics and half-life diagram

Open Nalmefene in the interactive console ↗

Memory aids: mascots and interaction avatars

Nalmefene Opvee mascot mnemonic cartoon
“Nail my fingers (to Open V)”
Nalmefene no kinetic interactions avatar
no kinetic interactions

Open Nalmefene in the interactive console ↗